Focus
670 results
Share buyback programme
L'Oréal announced to have today entered into a mandate with an investment services provider for the purchase of its own shares, under the authorisation approved by the Annual General Meeting of 23 April 2024, in order to proceed between now and June 30, 2025 to L’Oréal’s share buyback amounting to a maximum of 500 million euros and with a maximum n
Others
Explore the 2024 Annual Report
Other financial information
L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Tuesday 29 April 2025 and the 2024 Universal Registration Document.
TERMS OF INFORMATION AVAILABILITY REGARDING THE ANNUAL GENERAL MEETING OF TUESDAY 29 APRIL 2025
Others
Engages strategic partners to help support billions living with skin disease worldwide through knowledge, education, advocacy and best practice
Prizes
Secures coveted Top 50 spot in Fortune and Korn Ferry’s 2025 compilation of global business powerhouses
Prizes
Clichy, 25 February 2025 – L’Oréal Groupe has been recognized for its leadership in corporate transparency and performance on climate change, forests and water security by the global environmental non-profit, CDP, securing a place on its prestigious annual ‘A List’ for the ninth year running.
L'ORÉAL GROUPE SIGNS AN EXCLUSIVE AGREEMENT WITH JACQUEMUS
L’Oréal Groupe is delighted to announce a long-term, exclusive beauty partnership with JACQUEMUS, further solidified by a minority investment supporting their independent development.
Since 2009, JACQUEMUS has enlivened the codes of high fashion with ingenuity and imagination.
Results
Solid +5.1% Growth in a Challenging Context
Record Results, Reaching 20% Operating Margin
Sales: 43.48 billion euros, +5.6% reported and +5.1% like-for-like[1].
Another year of outperformance in a normalising global beauty market.
Like-for-like growth in all Divisions with three out of four outperforming the market.
Other financial information
L’Oréal announces today that it has agreed to sell approximately 29.6 million of Sanofi shares to Sanofi for €101.5 per share, for a total consideration of €3 billion.
Upon completion of the transaction and cancellation of the repurchased shares, L’Oréal will own 7.2% of Sanofi’s share capital and 13.1% of its voting rights[1].
